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Breast reconstruction using free tissue transfer is an increasingly utilised oncoplastic procedure. The aim was to review all bilateral
breast reconstructions using abdominal free flaps by a single surgeon over an 11-year period (2003–2014). A retrospective review
was performed on all patients who underwent bilateral breast reconstruction using abdominal free flaps between 2003 and 2014
by the senior author (DAM). Data analysed included patient demographics, indication for reconstruction, surgical details, and
complications. Fifty-five female patients (mean 48.6 years [24–71 years]) had bilateral breast reconstruction. The majority (41,
74.5%) underwent immediate reconstruction and DIEP flaps were utilised on 41 (74.5%) occasions. Major surgical complications
occurred in 6 (10.9%) patients, all of whichwere postoperative vascular compromise of the flap. Failure to salvage the reconstruction
occurred on 3 (5.5%) occasions resulting in a total flap failure rate of 2.7%. Obesity (>30 kg/m2) and age > 60 years were shown
to have a statistically increased risk of developing postoperative complications (𝑃 < 0.05). Our experience demonstrates that
abdominal free flaps for bilateral breast reconstruction fares well, with a flap failure rate of 2.7%. Increased body mass index and
patient age (>60 years) were associated with higher complication rates.
1. Introduction
In recent years, the number of bilateral breast reconstruc-
tion procedures has been increasing. This is a reflection
of advancements in breast cancer screening and diagnosis
supplemented by a desire for prophylactic surgery on the
contralateral side. Positive genetic markers for BRCA confer
an 85% lifetime risk of breast cancer, making this group of
patients highly suitable for prophylactic mastectomies and
reconstruction [1–4].
The options for reconstructing a breast mound following
mastectomy include implants with or without autologous
tissue flaps and can be performed at the time of the mastec-
tomy (immediate) or at a later stage (delayed). Expanders and
implants are a popular choice of breast reconstruction; how-
ever, the aesthetic outcomes are known to deteriorate with
time, particularly in the context of radiation therapy [5–8].
The 2011 National Mastectomy and Breast Reconstruction
audit, in which 8,159 women were sent patient satisfaction
questionnaires, identified superior reported outcomes in
patients who had received autologous tissue reconstruction
compared to those with implant only reconstruction.
There are various choices of flaps for both pedicled and
free flap breast reconstruction. Common pedicled options
include the latissimus dorsi flap and the pedicled transverse
rectus abdominis myocutaneous (TRAM) flap. The former
is a reliable and robust flap but often requires an implant
to augment the breast mound. The pedicled TRAM has
traditionally been the workhorse for autologous breast recon-
struction but is associated with higher rates of fat necrosis
and abdominal wall hernia compared to free abdominal flap
surgery. The free TRAM (where a small amount of muscle
between the perforators and main pedicle is taken with flap
harvest) has a role in certain patients but is known to have
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poorer outcomes compared to the muscle-preserving DIEP
perforator technique which is associated with minimal func-
tional loss and less postoperative pain [5–8]. The superficial
inferior epigastric artery (SIEA) flap supplies less skin and fat
abdominal tissue than theDIEP flap and is not always present
[9].
The DIEP flap is currently widely regarded as the gold
standard for breast reconstruction. It preserves the underly-
ing musculofascial layer which reduces postoperative pain,
duration of hospital admission, and long term donor site
morbidity [10–12].
The superior cosmetic outcomes and acceptable morbid-
ity rates of abdominal free flaps for unilateral breast recon-
struction have been well published; however, the literature on
bilateral procedures is limited.
The aim of this study was to review our experience with
bilateral abdominal free flap reconstruction, analyse patient
demographic and surgical data, and identify potential risk
factorswhichmay predispose to postoperative complications.
2. Materials and Methods
A retrospective case note review was performed of patients
who had undergone free abdominal tissue transfer for bilat-
eral breast reconstruction betweenAugust 2003 and February
2014. The list of patients was identified through a contempo-
raneous logbook of the senior author.
Patient demographic information including age, medi-
cal history, tobacco use, weight (body mass index (BMI)
(kg/m2)), and family and genetic history for breast cancer
were recorded.
Surgical data included indication for breast resection
(therapeutic or prophylactic), reconstructive timing, type of
abdominal flap harvested, ischaemic time, recipient vessels,
flap size, and hospital stay. Adjuvant radiotherapy and/or
chemotherapy were also documented.
Data on complications of surgery were reviewed. Compli-
cations were classified as early (occurring within seven days
of initial surgery) or late (occurring seven days after initial
surgery).
The unit of investigation for data relating to the flap
was the number of flaps (percentages). All other data were
described as number of patients (percentages). Chi-squared
tests for trend were used to compare 2 (two) groups. Chi-
squared𝑃 values of less than 0.05 were considered significant.
All statistical analyses were performed with IBM SPSS Statis-
tics Version 22.0. (IBM Corp. (2013)) [13].
3. Surgical Technique
The majority of patients underwent standard DIEP flap
reconstruction but the following may differ between units.
3.1. Preoperative. All patients are assessed at a preopera-
tive anaesthetic assessment clinic approximately one month
before surgery.They are admitted one day before surgery and
seen by the senior author. A handheld Doppler probe is used
to map potential perforators. We do not employ the routine
use of CT-angiography. Preoperative low molecular weight
heparin is not given and tamoxifen is not stopped prior to
surgery.
3.2. Anaesthetic Considerations. Following intubation, all
patients receive an arterial line and urinary catheter to
monitor cardiovascular status. The abdominal flap edges
are infiltrated with local anaesthetic and adrenaline. The
mixture used is 60mLs of 0.9% saline with 40mLs of 0.5%
levobupivicaine and 1mL of 1 : 1000 adrenaline. Pneumatic
compression stockings are utilised and patients receive intra-
venous Flucloxacillin on induction (clindamycin for patients
with a Penicillin allergy).
3.3. Surgery. The patient is prepped with Betadine and a
minimum of two surgeons operate simultaneously, the senior
author and a trainee. In immediate cases, the contralateral
flap is raised as the breast surgeon performs the mastectomy,
with or without axillary node clearance. The mastectomies
performed are commonly skin sparing. The superficial infe-
rior epigastric vessels, if present, are routinely harvested prior
to identifying DIEP perforators. Often two perforators are
harvested and motor nerves preserved. The decision to use
lateral or medial row perforators is made intraoperatively
depending on location and size. The recipient vessels of
choice, usually the internal mammary artery and vein, are
exposed by removing the third intercostal cartilage. Anasto-
moses are performed end to end with 9/0 Ethilon. Venous
couplers and intraoperative anticoagulants are not used. Two
drains are placed in each breast pocket and one drain is placed
on each side of the abdomen.
3.4. Postoperative Care. All patients return to a single room
on the high dependency unit (HDU) and have hourly clinical
flap observations overnight. All patients receive 24 hours of
intravenous Flucloxacillin and 2500 units of low molecular
weight heparin (LMWH) twice daily. Progressive mobilisa-
tion is encouraged and drains are kept until the patient is
mobile with less than 30mLs in 24 hours.
4. Results
Themedical records of 55 consecutive patients (mean age 48
years, range 24–71 years) undergoing simultaneous bilateral
breast reconstruction surgery with abdominal autologous
free flaps (𝑛 = 110) were reviewed. The average follow-up to
the time of this study was 46.1 (4–130) months. Patient
demographics are provided in Table 1.
The majority of patients (41; 75%) underwent immediate
reconstruction, 8 (15%) had a delayed reconstruction, and
6 (11%) had an immediate reconstruction unilaterally and
a delayed reconstruction contralaterally. Surgical data are
illustrated in Table 2.
Therapeutic surgery for unilateral or bilateral disease
accounted for 45 (81.8%) patient breast resections. Invasive
ductal carcinoma (22; 54%) and ductal carcinoma in situ
(DCIS) (6; 15%) were most frequently encountered.
In this series, 12 (22%) patients were BRCA positive,
and 12 (22%) had a strong family history of breast cancer
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Table 1: Demographics of patients undergoing bilateral breast
reconstruction.
Number of patients/flaps 55/110
Average age (years) 48.6 (24–71)
Average BMI (kg/m2) 28.1 (21–37)
Patients with medical comorbidities∗ (%) 16 (29)
Previous abdominal surgery (%) 25 (45)
Smokers (%) 7 (13)
Ex-smokers (%) 8 (15)
No family history of breast cancer∗∗ and BRCA
negative with disease 31 (56)
Family history of breast cancer (BRCA
negative) (%) 12 (22)
Family history of breast cancer with known
disease (%) 7 (13)
Family history of breast cancer with no known
disease (%) 5 (9.1)
BRACA gene positive (%) 12 (22)
BRACA positive with known disease 7 (13)
BRACA positive with no known disease 5 (9.1)
∗As per American Society of Anaesthesiology (ASA) II classification.
∗∗First-degree relative.
(disease affecting a first-degree female relative) but were
BRCA negative and 31 (56%) had no known familial or
genetic risk factors.
Of the BRCA positive patients, 7 (13%) underwent uni-
lateral therapeutic and contralateral prophylactic resection
and 5 (9%) had bilateral prophylactic (risk reducing) mas-
tectomies. Of the patients with a strong familial history
(BRCA negative), 7 (13%) underwent unilateral therapeutic
and contralateral prophylactic surgery and 5 (9%) patients
requested bilateral prophylactic resection of breast tissue in
the absence of identifiable pathology (Table 1).
Complications were classified as early (occurring within
seven days of initial surgery) or late (occurring more than
seven days after initial surgery). Forty-two patients (76%)
experienced one or more early or late complications of flap,
donor site, or both. All early complications (𝑛 = 6) were
vascular problems of the free flap and all of these underwent
immediate surgical exploration (Table 3). Three flaps were
salvaged and three eventually failed and required surgical
debridement. The most common late complication in the
breast/flap site was native breast skin necrosis 12 (11%) and the
most common late complication of the donor site was wound
dehiscence 23 (41%). This is shown in Table 4.
We performed analysis of risk factors to identify potential
predisposing features thatmay increase risk of complications.
Specifically we analysed smoking, raised BMI, previous
abdominal surgery, age, flap weight, and ischaemic time and
adjuvant radiation therapy.
Therewere 15 patientswhowere active or ex-smokers, and
this risk factor was not found to statistically increase the risk
of overall complications (𝑃 = 0.118).
Obese patients were found to have increased risk of
complications. Of 19 (35%) patients with a BMI greater than
Table 2: Surgical data for patients undergoing bilateral breast
reconstruction.
𝑛 (%)
Therapeutic surgery (known disease) 45 (82)
Prophylactic surgery (no known disease) 10 (18)
Immediate reconstruction 41 (75)
After prophylactic mastectomy 8 (15)
After therapeutic mastectomy 33 (60)
Delayed reconstruction, mean delay (years) 8 (15)
After prophylactic mastectomy 2 (3.6)
After therapeutic mastectomy 6 (11)
Immediate/delayed 6 (11)
Abdominal donor 55 (100)
DIEP 41 (75)
TRAM 7 (13)
SIEA 1 (1.8)
Combination 6 (11)
Average ischaemic time (mins) 68.57
Recipient vein
Internal mammary 100 (90)
Serratus 4 (3.6)
Thoracodorsal 2 (1.8)
Additional perforator 4 (3.6)
Recipient artery
Internal mammary 106 (96)
Serratus 2 (1.8)
Thoracodorsal 2 (1.8)
Average flap size (g) 692.25
Peri/post-op blood transfusion 8 (15)
Average hospital stay (days) 7.5
Average follow-up (months) 46.1
Adjuvant chemotherapy only 8 (15)
Adjuvant radiotherapy only 6 (11)
Adjuvant chemoradiotherapy 23 (42)
Table 3: Early complications requiring unplanned surgical inter-
vention.
Number (%)
Total 6/110
Vascular complications 6 (5.4)
Anastomotic venous complication 5
Anastomotic arterial complication 1
Partial flap failure 1
Total flap failure 3 (2.7)
or equal to 30 kg/m2, 15 (78.9%) (𝑃 = 0.019) experienced flap
complications, donor site complications, or both. This is in
contrast to the group of patients with a BMI< 30 kg/m2 where
flap/and or complication rate was 19 (53%).
Increasing age was associated with increased complica-
tions. The majority of patients (47; 85%) were under 60 years
of age, and, of eight patients older than 60 years, 6 (75%)
4 Plastic Surgery International
Table 4: Late complications.
Number (%)
Breast/flap complications 18/110 (16.4)
Native breast necrosis 12 (11)
Fat necrosis 4 (3.6)
Seroma 1 (0.9)
Haematoma 1
Donor site complications 23/55 (42)
Dehiscence 13 (24)
Seroma 5 (9.1)
Hernia 1 (1.8)
Hypertrophic scarring 2 (3.6)
Lymphedema 1 (1.8)
Late donor site complications requiring surgery 1 (1.8)
Recurrence/metastasis 3 (5.4)
experienced flap and/or abdominal complications postoper-
atively. There was a statistically increased risk of abdominal
wound dehiscence (2/8, 25%, 𝑃 = 0.02) and native breast
skin necrosis (2/8, 25%, 𝑃 = 0.039) in this >60-year-old
subgroup.
The weight of the flaps did not appear to affect compli-
cation rates and ranged in size from 280 g to 1200 g. Of 21
patients (38%) who had at least one flap exceeding 700 g in
weight, 15 (71%, 𝑃 = 0.078) experienced flap and/or abdom-
inal complications of surgery but this was not regarded
statistically significant.
In addition, flap ischaemic time did not appear to sta-
tistically affect complication rates. Ischaemic time, greater
than 90 minutes for one or both sides, occurred in 17 (31%)
patients, of which 12 (71%) (𝑃 = 0.143) encountered early or
late flap complications.
Previous abdominal surgery did not have an effect on
complication rates. Previous abdominal surgery was docu-
mented on 12 (22%) occasions and 4 (33%,𝑃 = 0.388) of these
developed a degree of wound dehiscence postoperatively.
Radiation therapy was utilised in 29 (53%) patients
(Table 2). Chest wall radiotherapy predating breast recon-
struction was used in 15 (27%) patients. Time delay following
radiotherapy to reconstruction varied from six months to
16 years and two (4%) patients experienced vascular com-
plications of the venous anastomoses, one intraoperatively
and one postoperatively. On surgical exploration, one was
reanastomosed to the internal mammary vessels with no
complications. One flap was anastomosed to the lateral chest
wall vessels due to a concern regarding the original recipient
chest wall vessel; this flap underwent partial flap failure.
Adjuvant radiotherapy after reconstruction was used in
14 (25%) patients with a mean duration of nine weeks
following surgery. One patient experienced a significant loss
of breast volume as a consequence of radiation treatment and
underwent lipofilling to restore breast bulk. There were no
other complications reported in this patient group.
Flap complications, abdominal complications, and asso-
ciated risk factors are demonstrated in Tables 5 and 6, respec-
tively. No patient encountered systemic complications as
a consequence of reconstructive breast surgery.Therewere no
pulmonary emboli, deep vein thrombosis, or sepsis events.
At the most recent follow-up, 30 (55%) patients had
underwent further elective surgery, with nipple tattoo or
nipple reconstruction accounting for half of these procedures.
Three (5.4%) patients had been diagnosed with recurrent
or metastatic disease and one (1.8%) was recently deceased
secondary to fulminant heart failure.
5. Discussion
The use of abdominal donor perforator free flaps for breast
reconstruction is widely advocated, with the DIEP flap
heralded as the gold standard for breast reconstruction. This
technique preserves the abdominal musculofascial system
and is recognised as providing a favourable aesthetic outcome
with low donor site morbidity (Figure 1) [14, 20]. The
use of the DIEP flap in unilateral breast reconstruction is
accepted and known to provide excellent cosmetic results
and an acceptable morbidity profile. However, the literature
on bilateral DIEP procedures is limited. A literature search
identified only six similar publications reporting a bilateral
DIEP series (Table 7). As illustrated, our early complications
associated with flap vascularity (11%) (0%–12.5%), partial flap
failure (1.8%) (0%–3.6%), and total flap failure (5.4%) (0%–
9.6%) are comparable with previous studies [14–19].
In our study, 42 patients (76%) experienced one or more
early or late complications of flap, donor site, or both.
All early complications (𝑛 = 6) involved vascular com-
promise of the flap and all of these required immediate
surgical intervention; five of these underwent reanastomosis
and threewere salvaged.One patient’s anastomosis was found
to have active flow during reexploration and reanastomo-
sis was not carried out. Anastomotic venous complication
occurred in all but 1 case. Of the failed flaps, two were venous
and one was arterial in origin and all of these had a failed
reanastomosis (Table 3). Venous anastomotic compromise
occurred more commonly than those of arterial origin, a
finding in keeping with similar literature [21, 22].
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Table 5: Flap complications and associated risk factors.
Native breast
necrosis 𝑛
(%)
𝑃 value Fat necrosis 𝑛(%) 𝑃 value
Corrected
vascular
problem 𝑛
(%)
𝑃 value
Partial/total
flap failure 𝑛
(%)
𝑃 value
Smoker/ex-smoker 7/15 (47) 0.774 2/15 (13) 1.000 0/3 0.250 2/15 (13) 1.000
Nonsmoker 5/40 (13) 2/40 (5) 3/3 (100) 2/40 (5)
High BMI 8/19 (42) 0.388 1/19 (5.2) 0.625 1/19 (5.2) 1.000 2/19 (11) 1.000
Normal BMI 4/36 (11) 3/36 (8.3) 2/36 (5.6) 2/36 (5.6)
Age > 60 2/8 (25) 0.039 0 0.125 0 0.250 0 0.125
Age < 60 10/47 (21) 4/47 (8.5) 3/47 (6.4) 4/47 (8.5)
Flap > 700 g 4/21 (19) 0.388 2/21 (9.5) 1.000 2/21 (9.5) 1.000 2/21 (9.5) 1.000
Flap < 700 g 8/34 (24) 2/34 (5.9) 1/34 (2.9) 2/34 (5.9)
Ischaemic time >
90 (mins) 5/17 (29) 0.774 1/17 (5.9) 0.625 2/17 (12) 1.000 2/17 (12) 1.000
Ischaemic time <
90 (mins) 7/38 (18) 3/38 (7.9) 1/38 (2.6) 2/38 (5.3)
Table 6: Donor site (abdomen) complications and associated risk factors.
Dehiscence 𝑛
(%) 𝑃 value Seroma 𝑛 (%) 𝑃 value
Smoker/ex-smoker 5/15 (33) 0.581 1/15 (6.7) 0.375
Nonsmoker 8/40 (20) 4/40 (10)
High BMI 7/19 (37) 1.000 4/19 (21) 0.375
Normal BMI 6/36 (17) 1/36 (2.8)
Previous abdominal
surgery 4/12 (33) 0.267 0 n/a
No previous abdominal
surgery 9/43 (21) 0 n/a
Age > 60 2/8 (25) 0.022 1/8 (13) 0.375
Age < 60 11/47 (23) 4/47 (8.5)
Flap > 700 g 8/21 (38) 0.581 2/21 (9.5) 1.000
Flap < 700 g 5/34 (15) 3/34 (8.8)
(a) (b)
Figure 1: ((a) Preoperative; (b) postoperative breast and nipple reconstruction) 56-year-old with invasive ductal carcinoma underwent
bilateral mastectomy and immediate bilateral DIEP reconstruction and delayed nipple reconstruction (consent obtained to use photographs).
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Table 7: Complication rates in comparative bilateral breast reconstruction literature [1].
Study 𝑁 TFF
𝑛
∗ (%)
PFF
𝑛
∗ (%)
VC
𝑛
∗ (%)
FN
𝑛
∗ (%)
H
𝑛
∗ (%)
AS
𝑛 (%)
AH
𝑛 (%)
Guerra et al. [14] 140 0 5 (3.6) 7 (5) 30 (21.4) — 30 (21.4) 3 (2.1)
Scheer et al. [15] 32 2 (6.3) 1 (3.1) 4 (12.5) 12 (37.5) 3 (9.4) 0 4 (12.5)
Hofer et al. [16] 44 1 (2.3) 1 (2.3) 2 (4.6) 4 (9.1) 2 (4.6) — —
Drazan et al. [17] 55 0 — 0 2 (3.6) 4 (7.3) 2 (3.6) —
Rao et al. [18] 114 11 (9.6) — — — — — —
Schaverien et al. [19] 10 0 0 0 1 (10) — 0 0
Our study 55 3 (5.4) 1 (1.8) 6 (10.9) 4 (7.3) 1 (1.8) 5 (5.4) 0
TFF: total flap failure; PFF: partial flap failure; VC: vascular complications; FN: fat necrosis of flap; H: haematoma of flap; AS: abdominal seroma; and AH-
abdominal hernia.
∗Unit of investigation is the “patient” and not the “flap” as per previous tables.
Factor V Leiden (FVL) genetic mutation was subse-
quently identified in one patient with total flap failure follow-
ing haematological investigation. Reports of free flap throm-
bosis in this group of patients leading to total or partial flap
loss have previously been published [23, 24]. FVL is the most
common inherited cause of hypercoagulability and leads to
resistance of activated protein C leading to an increased risk
of thrombotic events [25]. The prevalence of FVL is between
2% and 10% in the Caucasian population [26]. A personal
or family history of unexplained thrombosis should raise the
suspicion of FLV. It has been suggested that a preoperative
thrombophilia screen in high risk patients should be carried
out and consideration should be given for pedicled rather
than free flap reconstruction in this group of patients [25, 26].
Our first total flap failure (2005) precluded routine
haematological investigation for thrombophilia which is now
routine following vascular compromise of the flap. However,
the substantial size of flap (1200 g)may have contributed to its
vascular compromise and failure. A negative thrombophilia
screen was noted in the third patient and no obvious cause of
flap failure has subsequently been identified.
In similar works, late complications are inconsistently
defined and variably reported which makes comparison
difficult [1]. Our late complication rate may be attributed
to frequent outpatient follow-up over a long period of time
(mean 46.1 months). Previous comparable studies had a
shorter follow-up period (mean 14.6–32.1 months) [14, 16, 18].
Another possible contributing factor which may account for
the late complications observed is the higher mean BMI
(28.1 kg/m2) and/or increased active or recent tobacco usage
(27.2%) in our cohort of patients compared with analogous
literature on bilateral breast reconstruction [14–19].
Active or recent tobacco usewas associatedwith late com-
plications of the flap, including native breast skin necrosis, fat
necrosis, and flap failure.
Guerra et al. [14] did not find a significant increased
risk of fat necrosis or flap loss in smokers but did report an
increased risk of breast wound dehiscence in this group of
patients. Gill et al. [27] reviewed 758 unilateral and bilateral
DIEP flaps and identified an increased risk of donor site
complications in patients using tobacco. In contrast, our
study donor site complication rates were not statistically
significant among the smoking patient cohort.
Obesity is associatedwith an almost 12-fold increased risk
of postoperative complications after breast surgery. Obese
women often have bigger breasts which require a larger
abdominal donor graft to be harvested. Further complica-
tions include delayed wound healing and longer postopera-
tive recovery periods [28, 29].
The link between patient obesity and flap size is reflected
in the observed rate of flap and/or abdominal complications
in flaps exceeding 700 grams which was increased although
not statistically significant (𝑃 = 0.078). Interestingly, a similar
correlation between BMI, increased flap size, and overall
complication rates was not identified by previous research on
bilateral breast reconstruction [14].
The most common late complications of flap and donor
site were native breast skin necrosis (12/110; 11%) and abdom-
inal wound dehiscence (13/55; 24%), respectively (Figure 2).
Patients aged 60 years or older were noted to have a
statistically increased risk of developing these postoperative
complications (Tables 5 and 6). Concomitant disease and
decreased physical function are associated with higher levels
of surgical morbidity in elderly patients undergoing breast
surgery [30] and this is endorsed by the findings of this study.
Complications associated with radiotherapy in the con-
text of autologous breast reconstruction are a topic of debate
[31–35].
In our series of bilateral free tissue reconstructions, two
patients with preoperative chest wall irradiation experienced
vascular problems of the flap, one salvaged with no com-
plications and one salvaged with partial flap failure. Overall
complication rate in this patient cohort was not statistically
significant. This finding is in keeping with Berry et al. [31]
who on multivariate analysis identified no statistical differ-
ence in rates of complications between patients receiving
preoperative radiation therapy and those who did not.
In those patients undergoing postoperative radiotherapy,
only one patient was observed to have a reduction in breast
volume following adjuvant therapy. No other complications
were observed. This is similar to work by Chatterjee and
coworkers [32] who concluded that postoperative radiother-
apy did not significantly affect breast volume after reconstruc-
tion.
Overall complication rate in patients who had chest
wall irradiation after autologous breast reconstruction in our
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(a) (b) (c)
Figure 2: ((a) Preoperative; (b) 4 weeks after reconstruction; and (c) 6months after reconstruction) 42-year-old smoker with family history of
breast and ovarian cancer (BRACA negative) underwent risk reducing bilateral mastectomy and immediate DIEP reconstruction and delayed
nipple reconstruction. Note native breast necrosis and abdominal wound dehiscence (consent obtained to use photographs).
Figure 3: 43-year-old immediate bilateral DIEP reconstruction
for DCIS. Photograph taken after recent holiday abroad. Note
skin paddle pigmentation in response to abdominal sun exposure
(consent obtained to use photographs).
series was not significant, a finding consistent with some
literatures [34] and contradictory to others [33, 35].
The behaviour of autologous transplanted tissue and
its genetic tendency to mimic donor site are illustrated
in Figure 3. The phenomenon of unexposed reconstructed
breast skin paddles changing pigmentation in response to
abdominal sun exposure is not described in the literature
reviewed [5, 11, 12, 14–20].
Abdominal free flaps are unique as the use of this flap in
a unilateral setting precludes future use for the contralateral
side. In a recent publication, Wormald et al. [1] performed
a systematic review comparing the risks of unilateral versus
bilateral DIEP reconstructions and observed bilateral DIEP
reconstructions to be associated with a significantly higher
risk of total flap failure (RR 3.31, 𝑃 = 0.003) and breast
seroma (RR 7.15, 𝑃 = 0.03), while other outcomes were com-
parable. At present, in non-BRCA patients with unilateral
malignancy, bilateral mastectomies are not advocated as the
risks of developing breast cancer in the contralateral side are
comparable to the general female population. At our centre,
all patients with a positive family history are sent for genetic
testing, and lifetime risk estimates are provided for the patient
to make an informed decision on the appropriateness of a
contralateral prophylactic procedure. In this series, 12 (21.8%)
patients were BRCApositive and 12 (22%) had a strong family
history of breast cancer. Of these, 14 (26%) had identified
breast pathology and underwent therapeutic surgery and 10
(18%) opted to have bilateral prophylactic (risk reducing)
mastectomies.
Thirty-one (56%) patients with unilateral disease and
no identifiable genetic or familial predisposition underwent
bilateral mastectomy and reconstructive surgery. The deci-
sion to offer contralateral prophylactic mastectomy in a
non-BRCA patient with no family history is controversial.
However, in certain patients where there is a specific request
for contralateral risk reducing procedure, a joint decision can
be made with the breast surgeons, geneticist, oncologist, and
plastic surgeon.
Limitations of the study must be considered. Retrospec-
tive case series studies are at risk of selection and reporting
bias which reduce the reliability of results obtained. Prospec-
tive observational cohort studies to review objective and
patient associated outcomes and reduce bias are considered
preferable [1]. In addition, the relatively small size ensures
that the study is insufficiently powered to accurately detect
and predict uncommon but serious outcomes such as total
flap failure. Moreover, utilising “the flap” as the unit of
investigation for flap-associated data as opposed to “the
patient” underestimates the clinical adverse outcomes. It has
been suggested that using “the flap” as a data unit in bilateral
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breast reconstruction studies does not take into account “the
patient” who ultimately has suffered from the complication
that has arisen [1]. Finally undefined parameters pertaining
to observer descriptions of complication presentations are a
limitation of this study and similar studies.
6. Conclusion
Our experience demonstrates that abdominal free flaps for
bilateral breast reconstruction fare well, with a flap failure
rate of 2.7%. On analysis, smoking status, radiotherapy, flap
weight, previous abdominal surgery, and ischaemic time
were not associated with increased postoperative risks. We
have found that an increased BMI and increasing age (>60
years) were associated with higher complication rates. This is
useful information to help clinicians in decision making and
counselling of future patients. Abdominal free flap surgery for
bilateral breast reconstruction will continue to rise and the
increasing popularity is a reflection of the natural evolution of
breast reconstruction techniques to obtain maximal patient
satisfaction and outcome.
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